In Hong Kong on August 29, 2025, LifeTech Scientific Corporation, identified by stock code 1302.HK, released news about its focus on minimally invasive interventional solutions for cardio-cerebrovascular issues. The company, along with its subsidiaries as a group, operates in the medical device sector.